← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2006Last known activity
Nov 14, 2025
Timeline
1970s
- Jan 1, 1977
Cathay General Hospital— Founded
Drugs by trial phase (19 distinct, 12 trials)
Phase 4 (13 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma, Clear Cell
- Adenomyoepithelioma
- Anorexia
- Bronchopulmonary Dysplasia
- Cachexia
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Cerebral Infarction
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Ischemia
- Kidney Diseases
- Kidney Failure, Chronic
- Lung Diseases
- Ovarian Neoplasms
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Postoperative Pain
- Pruritus
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Stroke
- Weight Loss
Recent trials (18)
- NCT07237425OfficialPhase 1Nov 14, 2025
- NCT06815627OfficialPhase 3Feb 28, 2025
- NCT05338463Reponsible party - principal investigatorPhase 4Dec 1, 2021
- NCT05338463Lead sponsorPhase 4Dec 1, 2021
- NCT05338463Sponsor investigatorPhase 4Dec 1, 2021
- NCT05338463OfficialPhase 4Dec 1, 2021
- NCT05338463Overall official - principal investigatorPhase 4Dec 1, 2021
- NCT03713216Overall official - principal investigatorPhase 4Jul 1, 2018
- NCT03713216Lead sponsorPhase 4Jul 1, 2018
- NCT01852318CollaboratorPhase 4Apr 1, 2014
- NCT01824615Lead sponsorPhase 2Jan 1, 2013
- NCT01824615Overall official - principal investigatorPhase 2Jan 1, 2013
- NCT01532466Study directorN/AMar 1, 2011
- NCT01188824CollaboratorPhase 4Sep 1, 2010
- NCT01377285CollaboratorPhase 4Jun 1, 2010
Details
- Founded
- Taipei City, TW Jan 1, 1977
- Last known activity
- Nov 14, 2025